Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'FILGRASTIM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 239 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Wang, B; Ludden, TM; Cheung, EN; Schwab, GG; Roskos, LK
      Population pharmacokinetic-pharmacodynamic modeling of Filgrastim (r-metHuG-CSF) in healthy volunteers

      JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
    2. Green, RHA; Watson, D; Buchanan, S; Morrison, AE
      A prospective randomised concurrent comparison of the COBE Spectra Version4.7, COBE Spectra Version 6 (auto PBSC (TM)) and Haemonetics MCS plus cellseparators for leucapheresis in patients with haematological and non-haematological malignancies

      TRANSFUSION AND APHERESIS SCIENCE
    3. Goldman, SC; Bracho, F; Davenport, V; Slack, R; Areman, E; Shen, V; Lenarsky, C; Weinthal, J; Hughes, R; Cairo, MS
      Feasibility study of IL-11 and granulocyte colony-stimulating factor aftermyelosuppressive chemotherapy to mobilize peripheral blood stem cells fromheavily pretreated patients

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    4. Cairo, MS; Shen, V; Krailo, MD; Bauer, M; Miser, JS; Sato, JK; Blatt, J; Blazar, BR; Frierdich, S; Liu-Mares, W; Reaman, GH
      Prospective randomized trial between two doses of granulocyte colony-stimulating factor after ifosfamide, carboplatin, and etoposide in children withrecurrent or refractory solid tumors: A Children's Cancer Group report

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    5. Holdsworth, MT; Mathew, P
      Efficacy of colony-stimulating factors in acute leukemia

      ANNALS OF PHARMACOTHERAPY
    6. Altehoefer, C; Bertz, H; Ghanem, NA; Langer, M
      Extent and time course of morphological changes of bone marrow induced by granulocyte-colony stimulating factor as assessed by magnetic resonance imaging of healthy blood stem cell donors

      JOURNAL OF MAGNETIC RESONANCE IMAGING
    7. Rueda, A; Sevilla, I; Guma, J; Ribelles, N; Miramon, J; De Las Nieves, MA; Marquez, A; Alba, E
      Secondary prophylactic C-CSF (filgrastim) administration in chemotherapy of stage I and II Hodgkin's lymphoma with ABVD

      LEUKEMIA & LYMPHOMA
    8. Bauhofer, A; Lorenz, W; Stinner, B; Rothmund, M; Koller, M; Sitter, H; Celik, I; Farndon, JR; Fingerhut, A; Hay, JM; Lefering, R; Lorijn, R; Nystrom, PO; Schafer, H; Schein, M; Solomkin, J; Troidl, H; Volk, HD; Wittmann, DH; Wyatt, J
      Granulocyte-colony stimulating factor in the prevention of postoperative infectious complications and sub-optimal recovery from operation in patientswith colorectal cancer and increased preoperative risk (ASA 3 and 4) - Protocol for a controlled clinical trial developed by consensus of an international study group - Part two: design of the study

      INFLAMMATION RESEARCH
    9. Leoncini, O; Da Prada, GA; Pedrazzoli, P
      Costs of autologous stem-cell transplantation in solid tumours

      ANNALS OF ONCOLOGY
    10. Ji, SQ; Chen, HR; Xun, CQ; Wang, HX; Pan, SP; Xiao, MH
      The effect of G-CSF-stimulated donor marrow on engraftment and incidence of graft-versus-host disease in allogeneic bone marrow transplantation

      CLINICAL TRANSPLANTATION
    11. Menendez, P; Prosper, F; Bueno, C; Arbona, C; San Miguel, JF; Garcia-Conde, J; Sola, C; Hornedo, J; Cortes-Funes, H; Orfao, A
      Sequential analysis of CD34(+) and CD34(-) cell subsets in peripheral blood and leukapheresis products from breast cancer patients mobilized with SCFplus G-CSF and cyclophosphamide

      LEUKEMIA
    12. Langezaal, I; Coecke, S; Hartung, T
      Whole blood cytokine response as a measure of immunotoxicity

      TOXICOLOGY IN VITRO
    13. Bennett, CL; Hynes, D; Godwin, J; Stinson, TJ; Golub, RM; Appelbaum, FR
      Economic analysis of granulocyte colony stimulating factor as adjunct therapy for older patients with acute myelogenous leukemia (AML): Estimates from a Southwest Oncology Group clinical trial

      CANCER INVESTIGATION
    14. Korbling, M; Giralt, S; Khouri, I; Mirza, N; Donato, M; Anderlini, P; Fischer, H; Andreeff, M; McMannis, J; Champlin, R
      Donor lymphocyte apheresis for adoptive immunotherapy compared with blood stem cell apheresis

      JOURNAL OF CLINICAL APHERESIS
    15. Ji, SQ; Chen, HR; Wang, HX; Ma, JC; Pan, SP; Xue, M; Zhu, L; Liu, J; Xiao, MH; Zhou, LL
      Low incidence of severe aGVHD and accelerating hemopoietic reconstitution in Allo-BMT using lenograstim stimulated BM cells

      CHINESE MEDICAL JOURNAL
    16. Marmiroli, L
      Toxicity from combined modality therapy in head and neck cancer

      TUMORI
    17. Gandhi, SK; Arguelles, L; Boyer, JG
      Economic impact of neutropenia and febrile neutropenia in breast cancer: Estimates from two national databases

      PHARMACOTHERAPY
    18. Yeoh, EJA; Cunningham, JM; Yee, GC; Hunt, D; Houston, JA; Richardson, SL; Stewart, CF; Houghton, PJ; Bowman, LC; Gajjar, AJ
      Topotecan-filgrastim combination is an effective regimen for mobilizing peripheral blood stem cells

      BONE MARROW TRANSPLANTATION
    19. Mehta, J; Oyama, Y; Winter, J; Williams, S; Tallman, M; Singhal, S; Villa, M; Shook, T; Burt, R; Traynor, A; Soff, G; Masarik, S; Ramsey, G; Gordon, L
      CD34(+) cell collection efficiency does not correlate with the pre-leukapheresis hematocrit

      BONE MARROW TRANSPLANTATION
    20. Switzer, GE; Goycoolea, JM; Dew, MA; Graeff, EC; Hegland, J
      Donating stimulated peripheral blood stem cells vs bone marrow: do donors experience the procedures differently?

      BONE MARROW TRANSPLANTATION
    21. Mileshkin, L; Prince, HM; Rischin, D; Zimet, A
      Severe interstitial pneumonitis following high-dose cyclophosphamide, thiotepa and docetaxel: two case reports and a review of the literature

      BONE MARROW TRANSPLANTATION
    22. Osma, MM; Ortuno, F; Lozano, ML; Gomez-Espuch, J; Ayala, F; Sanchez-Serrano, I; Perez-Ceballos, E; Moraleda, JM; Vicente, V
      Administration of post-autologous PBSCT rhG-CSF is associated with long-term low concentrations of bone marrow hematopoietic progenitor cells

      BONE MARROW TRANSPLANTATION
    23. Weaver, CH; Schulman, KA; Buckner, CD
      Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim

      BONE MARROW TRANSPLANTATION
    24. von Wichmann, MA; Camino, X; Txoperena, G; Arrizabalaga, J; Rodriguez-Arrondo, F; Iribarren, JA
      Granulocyte colony-stimulating factor administration in human immunodeficiency virus-infected patients with prolonged neutropenia

      ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
    25. Stroncek, D; Anderlini, P
      Mobilized PBPC concentrates: a maturing blood component

      TRANSFUSION
    26. de Fabritiis, P; Iori, AP; Mengarelli, A; Gozzer, M; Ferrazza, G; De Propris, MS; Romano, A; Arcese, W
      CD34+cell mobilization for allogeneic progenitor cell transplantation: efficacy of a short course of G-CSF

      TRANSFUSION
    27. de la Rubia, J; Diaz, MA; Verdeguer, A; Pascual, MJ; Arbona, C; Arrieta, R; Brunet, S; Bargay, J; Martinez, C; Espigado, I; Serrano, D; Alegre, A; de Arriba, F; de la Serna, J; Zamora, C; Benlloch, L; Sanz, MA
      Donor age-related differences in PBPC mobilization with rHuG-CSF

      TRANSFUSION
    28. Schiller, M; Bohm, M; Zeidler, C; Germeshausen, M; Welte, K; Luger, TA; Bonsmann, G
      Cyclic Neutropenia with mutation in the gene encoding neutrophil elastase (ELA2)

      HAUTARZT
    29. Wunderink, RG; Leeper, KV; Schein, R; Nelson, S; DeBoisblanc, BP; Fotheringham, N; Logan, E
      Filgrastim in patients with pneumonia and severe sepsis or septic shock

      CHEST
    30. Perez-Calvo, J; Martinez-Aguillo, M; Garcia-Rayo, S; Cajal, TRY; Santisteban, M; Ordonez, JM; Inoges, S; Subira, ML; Martin-Algarra, S; Brugarolas, A
      Factors determining the actual received dose intensity in a program of multicyclic dose-intensive alternating chemotherapy with sequential stem cell support

      ACTA HAEMATOLOGICA
    31. Morstyn, G; Foote, MA; Walker, T; Molineux, G
      Filgrastim (r-metHuG-CSF) in the 21st century: SD/01

      ACTA HAEMATOLOGICA
    32. Henon, PR
      Hematopoietic growth factors and autologous peripheral blood stem cell transplantations: Why and when?

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    33. Meehan, KR; Areman, EM; Ericson, SG; Matias, C; Seifeldin, R; Schulman, K
      Mobilization, collection, and processing of autologous peripheral blood stem cells: Development of a clinical process with associated costs

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    34. Alcorn, MJ; Farrell, E; Barr, J; Pearson, C; Green, R; Holyoake, T
      The number of CD34(+) cells mobilized into the peripheral blood can predict the quality of subsequent collections

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    35. Edmonds, M; Bates, M; Doxford, M; Gough, A; Foster, A
      New treatments in ulcer healing and wound infection

      DIABETES-METABOLISM RESEARCH AND REVIEWS
    36. Braunschweig, I; Mirza, NQ; Rondon, G; Lauppe, J; Mehra, R; Gajewski, J; Korbling, M; Huh, YO; Geisler, D; Gee, AP; Champlin, R; Przepiorka, D
      High CD34 cell doses do not worsen regimen-related toxicity or early mortality after autologous blood stem cell transplantation for breast cancer

      CYTOTHERAPY
    37. Tejedor, M; Valerdi, JJ; Arias, F; Dominguez, MA; Pruja, E; Mendez, L; Illarramendi, JJ
      Hyperfractionated radiotherapy concomitant with cisplatin and granulocyte colony-stimulating factor (filgrastim) for laryngeal carcinoma

      CYTOKINES CELLULAR & MOLECULAR THERAPY
    38. Donato, M; Champlin, R
      Granulocyte colony-stimulating factor - Primed allogeneic bone marrow transplants: Capturing the advantages of blood stem cell transplants without increased risk of chronic graft-versus-host disease

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    39. Recchia, F; Accorsi, P; Bonfini, T; De Filippis, S; Grimaldi, M; Corrao, G; Rosselli, M; Amiconi, G; Iacone, A; Rea, S
      Randomized trial of sequential administration of G-CSF and GM-CSF vs. G-CSF alone following peripheral blood progenitor cell autograft in solid tumors

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    40. Baker, J; McCune, JS; Harvey, RD; Bonsignore, C; Lindley, CM
      Granulocyte colony-stimulating factor use in cancer patients

      ANNALS OF PHARMACOTHERAPY
    41. Jerjis, S; Croockewit, S; Preijers, F; Schaap, N; De Witte, T
      Impact of chemotherapy on the mobilisation, harvest and economic costs of autologous peripheral stem cell transplantation in patients with multiple myeloma

      LEUKEMIA & LYMPHOMA
    42. Lyman, GH
      A novel approach to maintain planned dose chemotherapy on time: a decision-making tool to improve patient care

      EUROPEAN JOURNAL OF CANCER
    43. Szlosarek, PW; Lofts, FJ; Pettengell, R; Carter, P; Young, M; Harmer, C
      Effective treatment of a patient with a high-grade endometrial stromal sarcoma with an accelerated regimen of carboplatin and paclitaxel

      ANTI-CANCER DRUGS
    44. Schafer, H; Hubel, K; Bohlen, H; Mansmann, G; Hegener, K; Richarz, B; Oberhauser, F; Wassmer, G; Holscher, AH; Pichlmaier, H; Diehl, V; Engert, A
      Perioperative treatment with Filgrastim stimulates granulocyte function and reduces infectious complications after esophagectomy

      ANNALS OF HEMATOLOGY
    45. Dubreuil-Lemaire, ML; Gori, A; Vittecoq, D; Panelatti, G; Tharaux, F; Palisses, R; Gharakhanian, S; Rozenbaum, W
      Lenograstim for the treatment of neutropenia in patients receiving ganciclovir for cytomegalovirus infection: a randomised, placebo-controlled trial in AIDS patients

      EUROPEAN JOURNAL OF HAEMATOLOGY
    46. Morrison, AE; Watson, D; Buchanan, S; Green, RHA
      Prospective randomised concurrent comparison of the COBE Spectra Version 4.7, COBE Spectra Version 6 (Auto PBSC (TM)), and haemonetics MCS+ cell separators for leucapheresis in patients with haematological and non haematological malignancies

      JOURNAL OF CLINICAL APHERESIS
    47. Neymark, N; Rosti, G
      Patient management strategies and transplantation techniques in European stem cell transplantation centers offering breast cancer patients high-dose chemotherapy with peripheral blood stem cell support: a joint report from the EORTC and EBMT

      HAEMATOLOGICA
    48. Olavarria, E; Parker, S; Craddock, C; Philpott, N; Tiniakou, M; Chase, A; Kanfer, E; Apperley, JF; Goldman, JM
      Collection of Ph-negative progenitor cells from interferon-responsive patients with chronic myeloid leukemia: effect of granulocyte-colony-stimulating factor mobilization

      HAEMATOLOGICA
    49. Pitini, V; Ciccolo, A; Arrigo, C; Aloi, G; Micali, C; La Torre, F
      Spontaneous rupture of spleen during peripheral blood stem cell mobilization in a patient with breast cancer

      HAEMATOLOGICA
    50. Barrios, L; Poletti, OH; Agustini, MI
      The influence of recombinant human granulocyte colony-stimulating factor on granulopoiesis in mice recovering from cyclophosphamide treatment

      METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    51. Arpaci, F; Komurcu, S; Ozturk, B; Ozet, A; Kinalp, C; Sengul, A; Beyzadeoglu, M; Pak, Y; Yalcin, A
      A successful and simplified filgrastim primed single apheresis method without large volume apheresis for peripheral blood stem cell collection

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    52. Carlo-Stella, C; Cesana, C; Regazzi, E; Falzetti, F; Aversa, F; Rizzoli, V; Martelli, M; Tabilio, A
      Peripheral blood progenitor cell mobilization in healthy donors receiving recombinant human granulocyte colony-stimulating factor

      EXPERIMENTAL HEMATOLOGY
    53. Aladdin, H; Ullum, H; Katzenstein, T; Gerstoft, J; Skinhoj, P; Pedersen, BK
      Immunological and virological changes in antiretroviral naive human immunodeficiency virus infected patients randomized to G-CSF or placebo simultaneously with initiation of HAART

      SCANDINAVIAN JOURNAL OF IMMUNOLOGY
    54. Lowenthal, RM; Graham, SR
      Does hemopoietic stem cell transplantation have a role in treatment of severe rheumatoid arthritis?

      JOURNAL OF CLINICAL IMMUNOLOGY
    55. Hilbe, W; Nussbaumer, W; Bonatti, H; Thaler, J; Niederwieser, D; Nachbaur, D
      Unusual adverse events following peripheral blood stem cell (PBSC) mobilisation using granulocyte colony stimulating factor (G-CSF) in healthy donors

      BONE MARROW TRANSPLANTATION
    56. Madero, L; Gonzalez-Vicent, M; Molina, J; Madero, R; Quintero, V; Diaz, MA
      Use of concurrent G-CSF plus GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells in children with malignant disease

      BONE MARROW TRANSPLANTATION
    57. Bolwell, B; Vredenburgh, J; Overmoyer, B; Gilbert, C; Chap, L; Menchaca, DM; Cruickshank, S; Glaspy, J
      Phase 1 study of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in breast cancer patients after autologous peripheral blood progenitor cell (PBPC) transplantation

      BONE MARROW TRANSPLANTATION
    58. Lee, V; Li, CK; Shing, MMK; Chik, KW; Li, K; Tsang, KS; Zhao, DC; Lai, DH; Wong, A; Yuen, PMP
      Single vs twice daily G-CSF dose for peripheral blood stem cells harvest in normal donors and children with non-malignant diseases

      BONE MARROW TRANSPLANTATION
    59. Singhal, S; Powles, R; Kulkarni, S; Treleaven, J; Sirohi, B; Millar, B; Shepherd, V; Saso, R; Rowland, A; Long, S; Cabral, S; Horton, C; Mehta, J
      Comparison of marrow and blood cell yields from the same donors in a double-blind, randomized study of allogeneic marrow vs blood stem cell transplantation

      BONE MARROW TRANSPLANTATION
    60. Basara, N; Schmetzer, B; Blau, IW; Bischoff, M; Gunzelmann, S; Kirsten, D; Fauser, AA
      Lenograstim-mobilized peripheral blood progenitor cells in volunteer donors: an open label randomized split dose escalating study

      BONE MARROW TRANSPLANTATION
    61. Cavallaro, AM; Lilleby, K; Majolino, I; Storb, R; Appelbaum, FR; Rowley, SD; Bensinger, WI
      Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor

      BONE MARROW TRANSPLANTATION
    62. Vigani, A; Pensa, F; Vaira, F; Bancalari, L; Cordani, S; Maggiani, R; Canessa, P; Pronzato, P
      Sequential high dose-density chemotherapy with two active regimens for advanced small cell lung cancer.

      ANTICANCER RESEARCH
    63. Gruson, D; Hilbert, G; Vargas, F; Valentino, R; Chene, G; Boiron, JM; Reiffers, J; Gbikpi-Benissan, G; Cardinaud, JP
      Impact of colony-stimulating factor therapy on clinical outcome and frequency rate of nosocomial infections in intensive care unit neutropenic patients

      CRITICAL CARE MEDICINE
    64. Pettila, V; Takkunen, O; Varpula, T; Markkola, A; Porkka, K; Valtonen, V
      Safety of granulocyte colony-stimulating factor (filgrastim) in intubated patients in the intensive care unit: Interim analysis of a prospective, placebo-controlled, double-blind study

      CRITICAL CARE MEDICINE
    65. van der Poll, T
      The use of granulocyte colony-stimulating factor in critically ill patients

      CRITICAL CARE MEDICINE
    66. Stroncek, DF; Confer, DL; Leitman, SF
      Peripheral blood progenitor cells for HPC transplants involving unrelated donors

      TRANSFUSION
    67. Grudeva-Popova, Z; Karnolski, I
      Filgrastim administration in acute nonlymphoblastic leukemia

      TERAPEVTICHESKII ARKHIV
    68. Medinger, P; Tissot, JD; de Faveri, GN; Kovacsovics, TJ; Perey, L; Schneider, P; Zwicky, C
      Autologous transplantation of peripheral blood stem cells for haematological malignancies. Part I: patients

      SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT
    69. Aladdin, H; Ullum, H; Nielsen, SD; Espersen, C; Mathiesen, L; Katzenstein, TL; Gerstoft, J; Skinhoj, P; Pedersen, BK
      Granulocyte colony-stimulating factor increases CD4(+) T cell counts of human immunodeficiency virus-infected patients receiving stable, highly active antiretroviral therapy: Results from a randomized, placebo-controlled trial

      JOURNAL OF INFECTIOUS DISEASES
    70. Wenisch, C; Werkgartner, T; Sailer, H; Patruta, S; Krause, R; Daxboeck, F; Parschalk, B
      Effect of preoperative prophylaxis with filgrastim in cancer neck dissection

      EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    71. Kushner, BH; Heller, G; Kramer, K; Cheung, NKV
      Granulocyte-colony stimulating factor and multiple cycles of strongly myelosuppressive alkylator-based combination chemotherapy in children with neuroblastoma

      CANCER
    72. Spaeth, D; Geoffrois, L; Conroy, T
      Prevention and treatment of hematological complications associated with oncological chemotherapy - News on hematopoietic growth factors

      BULLETIN DU CANCER
    73. Anderlini, P; Donato, M; Lauppe, MJ; Huh, YO; Martin, TG; Chan, KW; Champlin, PE; Korbling, M
      A comparative study of once-daily versus twice-daily filgrastim administration for the mobilization and collection of CD34(+) peripheral blood progenitor cells in normal donors

      BRITISH JOURNAL OF HAEMATOLOGY
    74. Machida, U; Tojo, A; Takahashi, S; Iseki, T; Ooi, J; Nagayama, H; Shirafuji, N; Mori, SI; Wada, Y; Ogami, K; Yamada, Y; Sakamaki, H; Maekawa, T; Tani, K; Asano, S
      The effect of granulocyte colony-stimulating factor administration in healthy donors before bone marrow harvesting

      BRITISH JOURNAL OF HAEMATOLOGY
    75. McNiece, I; Jones, R; Bearman, SI; Cagnoni, P; Nieto, Y; Franklin, W; Ryder, J; Steele, A; Stoitz, J; Russell, P; McDermitt, J; Hogan, C; Murphy, J; Shpall, EJ
      Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer

      BLOOD
    76. Paquette, RL; Dergham, ST; Karpf, E; Wang, HJ; Slamon, DJ; Souza, L; Glaspy, JA
      Ex vivo expanded unselected peripheral blood: progenitor cells reduce posttransplantation neutropenia, thrombocytopenia, and anemia in patients with breast cancer

      BLOOD
    77. Nakamura, K; Kobayashi, M; Konishi, N; Kawaguchi, H; Miyagawa, S; Sato, T; Toyoda, H; Komada, Y; Kojima, S; Katoh, O; Ueda, K
      Abnormalities of primitive myeloid progenitor cells expressing granulocytecolony-stimulating factor receptor in patients with severe congenital neutropenia

      BLOOD
    78. Schiffer, CA; Miller, K; Larson, RA; Amrein, PC; Antin, JH; Zani, VJ; Stone, RM
      A double-blind, placebo-controlled trial of pegylated recombinant human megakaryocyte growth and development factor as an adjunct to induction and consolidation therapy for patients with acute myeloid leukemia

      BLOOD
    79. Zeidler, C; Welte, K; Barak, Y; Barriga, F; Bolyard, AA; Boxer, L; Cornu, G; Cowan, MJ; Dale, DC; Flood, T; Freedman, M; Gadner, H; Mandel, H; O'Reilly, RJ; Ramenghi, U; Reiter, A; Skinner, R; Vermylen, C; Levine, JE
      Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation

      BLOOD
    80. Crawford, J; Tomita, DK; Mazanet, R; Glaspy, J; Ozer, H
      Reduction of oral mucositis by filgrastim (r-metHuG-CSF) in patients receiving chemotherapy

      CYTOKINES CELLULAR & MOLECULAR THERAPY
    81. Schneider, SB; Nishimura, RD; Zimmerman, RP; Tran, L; Shiplacoff, J; Tormey, M; Contreras, R; Juillard, GF
      Filgrastim (r-metHuG-CSF) and its potential use in the reduction of radiation-induced oropharyngeal mucositis: An interim look at a randomized, double-blind, placebo-controlled trial

      CYTOKINES CELLULAR & MOLECULAR THERAPY
    82. Gabus, R; Magarinos, A; Zamora, M; De Lisa, E; Landoni, AI; Martinez, G; Canessa, C; Giordano, H; Bodega, E
      Evaluation of hematopoietic progenitors in hematopoietic progenitor cell transplants. CD34+dose effect in marrow recovery. Retrospective analysis in 38 patients

      HEMATOLOGY AND CELL THERAPY
    83. Vial, T; Gallant, C; Choquet-Kastylevsky, G; Descotes, J
      Treatment of drug-induced agranulocytosis with haematopoietic growth factors - A review of the clinical experience

      BIODRUGS
    84. Tognoni, A; Cadenotti, L; Pensa, F; Vaira, F; Vigani, A; Bancalari, L; Cordani, S; Maggiani, R; Canessa, PA; Pronzato, P
      A phase II study of a three-drug combination (cisplatin, ifosfamide and vinorelbine) plus granulocyte-colony stimulating factor in advanced non smallcell lung cancer

      JOURNAL OF CHEMOTHERAPY
    85. Burtness, B; Windsor, S; Holston, B; DiStasio, S; Staugaard-Hahn, C; Abrantes, J; Kneuper-Hall, R; Farber, L; Orell, J; Bober-Sorcinelli, K; Haffty, BG; Reiss, M
      Adjuvant sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide (ATC) for high-risk breast cancer is feasible in the community setting

      CANCER JOURNAL FROM SCIENTIFIC AMERICAN
    86. Bernstein, BJ; Blanchard, LM
      Economic and clinical impact of a pharmacy-based filgrastim protocol in oncology patients

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    87. Piscitelli, SC
      Update on the treatment of neutropenia in HIV-infected patients - Introduction

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    88. Pitrak, DL
      Neutrophil deficiency and dysfunction in HIV-infected patients

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    89. Wong, RJ
      Treatment of HIV-related neutropenia

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    90. Dlubek, D; Pacuszko, T; Suchnicki, K; Lange, A
      G-CSF-mobilized leukapheresis products: Cellular characteristics and clinical performance in allografting

      JOURNAL OF HEMATOTHERAPY
    91. Lefrere, F; Bernard, M; Audat, F; Cavazzana-Calvo, M; Belanger, C; Hermine, O; Arnulf, B; Buzyn, A; Varet, B
      Comparison of lenograstim vs filgrastim administration following chemotherapy for peripheral blood stem cell (PBSC) collection: a retrospective studyof 126 patients

      LEUKEMIA & LYMPHOMA
    92. D'Hondt, L; Emmons, RVB; Andre, M; Guillaume, T; Feyens, AM; Canon, JL; Humblet, Y; Longueville, J; Symann, M
      The administration of 10 mu g/kg granulocyte colony-stimulating factor (G-CSF) alone results in a successful peripheral blood stem cell collection when previous mobilization with chemotherapy and hematopoietic growth factor failed

      LEUKEMIA & LYMPHOMA
    93. Dreger, P; Schmitz, N
      Stem cell mobilization in healthy donors: Current status

      INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN
    94. Stroncek, DF; Clay, ME; Jaszcz, W; Lennon, S; Smith, J; McCullough, J
      Collection of two peripheral blood stem cell concentrates from healthy donors

      TRANSFUSION MEDICINE
    95. Siena, S; Bregni, M; Gianni, AM
      Mobilization of peripheral blood progenitor cells for autografting: chemotherapy and G-CSF or GM-CSF

      BAILLIERES CLINICAL HAEMATOLOGY
    96. Wiik, HT; Syrjala, HP; Silvennoinen-Kassinen, SH; Laurila, JJ; Haukipuro, KA
      Use of recombinant human granulocyte-colony stimulating factor in colorectal surgery

      EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
    97. Talbot, SM; Westerman, DA; Grigg, AP; Toner, GC; Wolf, M; Bishop, J; McKendrick, J; Zalcberg, J; Levi, J; Fox, RM; Green, MD
      Phase I and subsequent phase II study of filgrastim (r-met-HuG-CSF) and dose intensified cyclophosphamide plus epirubicin in patients with non-Hodgkin's lymphoma and advanced solid tumors

      ANNALS OF ONCOLOGY
    98. Bennett, CL; Bishop, MR; Tallman, MS; Somerfield, MR; Feinglass, J; Smith, TJ
      The association between physician reimbursement in the US and use of hematopoietic colony stimulating factors as adjunct therapy for older patients with acute myeloid leukemia: Results from the 1997 American Society of Clinical Oncology survey

      ANNALS OF ONCOLOGY
    99. Cohn, LA; Rewerts, JM; McCaw, D; Boon, GD; Wagner-Mann, C; Lothrop, CD
      Plasma granulocyte colony-stimulating factor concentrations in neutropenic, parvoviral enteritis-infected puppies

      JOURNAL OF VETERINARY INTERNAL MEDICINE
    100. Schulman, KA; Birch, R; Zhen, B; Pania, N; Weaver, CH
      Effect of CD34(+) cell dose on resource utilization in patients after high-dose chemotherapy with peripheral-blood stem-cell support

      JOURNAL OF CLINICAL ONCOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/02/20 alle ore 00:42:45